---
title: 'Treatment Strategies and Prognostic Factors in Secondary Central Nervous System
  Lymphoma: A Multicenter Study of 124 Patients'
date: '2023-07-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37492436/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230726180750&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Secondary central nervous system lymphoma (SCNSL) is a rare and difficult
  to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous
  system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively
  treated and with clinical long-term follow-up were included. Initial histopathology,
  as divided in low-grade, other aggressive, and diffuse large B-cell lymphoma (DLBCL),
  was of prognostic significance. Overall response to induction treatment was ...
disable_comments: true
---
Secondary central nervous system lymphoma (SCNSL) is a rare and difficult to treat type of Non-Hodgkin lymphoma characterized by systemic and central nervous system (CNS) disease manifestations. In this study, 124 patients with SCNSL intensively treated and with clinical long-term follow-up were included. Initial histopathology, as divided in low-grade, other aggressive, and diffuse large B-cell lymphoma (DLBCL), was of prognostic significance. Overall response to induction treatment was ...